In the BioHarmony Drug Report Database

"Preview" Icon

Desvenlafaxine

Desvenlafaxine, Khedezla (desvenlafaxine) is a small molecule pharmaceutical. Desvenlafaxine was first approved as Desvenlafaxine on 2013-03-04. It is used to treat major depressive disorder in the USA. The pharmaceutical is active against sodium-dependent noradrenaline transporter and sodium-dependent serotonin transporter. In addition, it is known to target sodium-dependent dopamine transporter.

 

Trade Name

 

Desvenlafaxine, Khedezla
 

Common Name

 

desvenlafaxine
 

ChEMBL ID

 

CHEMBL1118
 

Indication

 

major depressive disorder
 

Drug Class

 

Antianxiety, antidepressant inhibitor of norepinephrine and dopamine re-uptake

Image (chem structure or protein)

Desvenlafaxine structure rendering